CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Gemcitabine Therapy in Patients with Advanced Pancreatic Cancer
Young Joo Min, Kwang Ro Joo, Neung Hwa Park, Tae Kwon Yun, Yang Won Nah, Chang Woo Nam, Jae Hoo Park
Korean J Intern Med. 2002;17(4):259-262.   Published online 2002 December 1    DOI: https://doi.org/10.3904/kjim.2002.17.4.259

Excel Download

Activity of gemcitabine in patients with advanced pancreatic carcinoma: A review
Cancer. 1996;78(S3):633-638   Crossref logo
Link1 Link2

Activity of gemcitabine in patients with advanced pancreatic carcinoma: A review
Cancer. 1996;78(S3):633-638   Crossref logo
Link1

Activity of gemcitabine in patients with advanced pancreatic carcinoma: A review
Cancer. 1996;78(3):633-638   Crossref logo
Link1

Activity of gemcitabine in patients with advanced pancreatic carcinoma: A review
Cancer. 1996;78(3):633-638   Crossref logo
Link1 Link2

Neoadjuvant gemcitabine, docetaxel, and capecitabine followed by gemcitabine and capecitabine/radiation therapy and surgery in locally advanced, unresectable pancreatic adenocarcinoma
Cancer. 2014;121(5):673-680   Crossref logo
Link1 Link2

Predictors for resectability and survival in locally advanced pancreatic cancer after gemcitabine-based neoadjuvant therapy
Pancreatology. 2016;16(4):S18   Crossref logo
Link1 Link2

PCA6: COST-EFFECTIVENESS OF GEMCITABINE AS FIRST-LINE THERAPY FOR PATIENTS WITH ADVANCED PANCREATIC CANCER
Value in Health. 1999;2(1):22   Crossref logo
Link1 Link2

Gemcitabine plus nab-paclitaxel in patients with previously treated for advanced pancreatic cancer
Pancreatology. 2016;16(4):S174   Crossref logo
Link1 Link2

Retrospective analysis of fixed dose rate infusion of gemcitabine and S-1 combination therapy (FGS) as salvage chemotherapy in patients with gemcitabine-refractory advanced pancreatic cancer: inflammation-based prognostic score predicts survival
Cancer Chemotherapy and Pharmacology. 2014;75(3):457-464   Crossref logo
Link1 Link2 Link3

A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer
British Journal of Cancer. 2002;87(2):161-167   Crossref logo
Link1 Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Korean J Intern Med has participated in CrossRef Text and Data Mining service since August 31, 2015.